Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
Kahn Brothers Group Portfolio 13F
Kahn Brothers Group Holdings Activity
- Portfolio value:
- $694.72M≈ (-$65M≈)
- Previous value:
- $759.63M≈
- # of changes:
- 33
- New positions:
- 0
- Reported for:
- 31 Mar 2023 (Q1)
- Latest filing date:
- 12 May 2023
Kahn Brothers Group has disclosed a total of 33 changes to the portfolio in the (2023 Q1) SEC report(s): increased the number of shares of 4 and decreased the number of shares of 29 position(s).
What stocks did Kahn Brothers Group buy in 2023 Q1?
What did Kahn Brothers Group invest in during 2023 Q1?
In the 2023 Q1 report(s) the following changes have been made to the top investments: (BP) BP PLC-SPONS ADR (reduced shares -9.49%), (MRK) Merck & Company Inc (reduced shares -1.49%), (BMY) Bristol-Myers Squibb Company (reduced shares -1.47%), (FLG) Flagstar Financial, Inc (added shares +7.15%) and (AGO) ASSURED GUARANTY LTD (reduced shares -7.09%).
33 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
JPMorgan Chase & Co
|
+36.04%
|
+1,000
|
3,775
|
+0.02%
|
$130.33
|
+171.36%($353.66)
|
0.07%
|
2020 Q1
|
≈ 3.25 years
|
|
|
|
Flagstar Financial, Inc
|
+7.15%
|
+426,402
|
6,389,144
|
+0.55%
|
$9.04
|
+58.13%($14.30)
|
8.31%
|
2013 Q2 or earlier
|
≈ 10.00+ years
|
|
|
|
Citigroup Inc
|
+4.20%
|
+49,021
|
1,217,553
|
+0.33%
|
$46.89
|
+183.94%($133.14)
|
8.22%
|
2013 Q2 or earlier
|
≈ 10.00+ years
|
|
|
|
GlaxoSmithKline PLC ADR
|
+4.12%
|
+50,570
|
1,277,476
|
+0.26%
|
$35.58
|
+45.66%($51.82)
|
6.54%
|
2014 Q3
|
≈ 8.75 years
|
|
|
|
VIEWRAY INC
|
-0.16%
|
-2,620
|
1,620,797
|
-0%
|
$3.46
|
-100.00%($0.00)
|
0.81%
|
2019 Q2
|
≈ 4.00 years
|
|
|
|
Trinity Place Holdings Inc
|
-0.22%
|
-3,228
|
1,492,415
|
-0%
|
$0.48
|
-95.19%($0.02)
|
0.10%
|
2013 Q2 or earlier
|
≈ 10.00+ years
|
|
|
|
BlackBerry Ltd
|
-0.57%
|
-8,053
|
1,412,945
|
-0%
|
$4.56
|
+88.93%($8.62)
|
0.93%
|
2013 Q3
|
≈ 9.75 years
|
|
|
|
Rafael Holdings, Inc
|
-0.66%
|
-1,848
|
279,534
|
-0%
|
$1.55
|
+24.40%($1.93)
|
0.06%
|
2018 Q1
|
≈ 5.25 years
|
|
|
|
Viatris Inc
|
-0.72%
|
-537
|
73,637
|
-0%
|
$9.61
|
+82.48%($17.54)
|
0.10%
|
2020 Q4
|
≈ 2.50 years
|
|
|
|
Pfizer Inc
|
-0.83%
|
-8,644
|
1,029,662
|
-0.05%
|
$40.80
|
-38.48%($25.10)
|
6.05%
|
2013 Q2 or earlier
|
≈ 10.00+ years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.